Boardroom Briefing

Major IPO for Malin

✽ Biotech firm Malin has raised up to €330 million in one of Europe’s biggest life science IPOs.

The Irish company, which was set up by a number of former Elan executives, beat its target range of €275 to €325 million. The company will be admitted to Ireland’s ESM (Enterprise Securities Market) on Wednesday.

Dr Adrian Howd, Malin’s chief executive, said the company was “very gratified at the level of investor support and ...